Proceedings from the Second Annual Miami General Medical
Oncology Symposium — Part 7: Breast Cancer. Featuring perspectives
from Drs Harold J Burstein, Charles E Geyer Jr, Erika Hamilton and
Virginia Kaklamani.
ER-Positive, HER2-Negative Breast Cancer
First-Line Endocrine Treatment for HR-Positive, HER2-Negative
Metastatic Breast Cancer — Dr Hamilton
Treatment of Metastatic Breast Cancer Progressing on a CDK4/6
Inhibitor — Dr Kaklamani
HER2-Positive and Triple-Negative Breast
Cancer
New Agents in HER2-Positive Metastatic Breast Cancer — Dr
Geyer
Checkpoint Inhibitors in Breast Cancer in the Metastatic and
Neoadjuvant Setting — Dr Burstein
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.